AEDIFICA (AED.BR) Stock Fundamental Analysis

EBR:AED • BE0003851681

77.15 EUR
-1 (-1.28%)
Last: Feb 25, 2026, 03:51 PM
Fundamental Rating

4

AED gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. There are concerns on the financial health of AED while its profitability can be described as average. AED is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year AED was profitable.
  • AED had a positive operating cash flow in the past year.
  • Each year in the past 5 years AED has been profitable.
  • AED had a positive operating cash flow in each of the past 5 years.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.73%, AED is in line with its industry, outperforming 59.52% of the companies in the same industry.
  • The Return On Equity of AED (4.96%) is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 3.52%, AED is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for AED is in line with the industry average of 3.46%.
  • The last Return On Invested Capital (3.52%) for AED is above the 3 year average (3.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROIC 3.52%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • With a decent Profit Margin value of 49.82%, AED is doing good in the industry, outperforming 64.29% of the companies in the same industry.
  • In the last couple of years the Profit Margin of AED has declined.
  • AED has a Operating Margin of 77.70%. This is in the better half of the industry: AED outperforms 71.43% of its industry peers.
  • In the last couple of years the Operating Margin of AED has remained more or less at the same level.
  • The Gross Margin of AED (97.93%) is better than 97.62% of its industry peers.
  • AED's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AED is destroying value.
  • AED has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AED has more shares outstanding
  • The debt/assets ratio for AED is higher compared to a year ago.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • AED has an Altman-Z score of 0.93. This is a bad value and indicates that AED is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.93, AED perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
  • AED has a debt to FCF ratio of 24.91. This is a negative value and a sign of low solvency as AED would need 24.91 years to pay back of all of its debts.
  • AED has a worse Debt to FCF ratio (24.91) than 66.67% of its industry peers.
  • AED has a Debt/Equity ratio of 0.58. This is a neutral value indicating AED is somewhat dependend on debt financing.
  • AED's Debt to Equity ratio of 0.58 is fine compared to the rest of the industry. AED outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Altman-Z 0.93
ROIC/WACC0.56
WACC6.3%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • AED has a Current Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AED has a Current ratio of 0.35. This is comparable to the rest of the industry: AED outperforms 42.86% of its industry peers.
  • A Quick Ratio of 0.35 indicates that AED may have some problems paying its short term obligations.
  • AED has a Quick ratio (0.35) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 114.94% over the past year.
  • Measured over the past years, AED shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.20% on average per year.
  • AED shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.06%.
  • Measured over the past years, AED shows a very strong growth in Revenue. The Revenue has been growing by 23.35% on average per year.
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%

3.2 Future

  • AED is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.19% yearly.
  • AED is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.12% yearly.
EPS Next Y4.17%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
EPS Next 5YN/A
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.11, the valuation of AED can be described as correct.
  • AED's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 26.98, AED is valued a bit cheaper.
  • AED is valuated correctly with a Price/Forward Earnings ratio of 14.68.
  • Based on the Price/Forward Earnings ratio, AED is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.
  • The average S&P500 Price/Forward Earnings ratio is at 28.01. AED is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.11
Fwd PE 14.68
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as AED.
  • 78.57% of the companies in the same industry are cheaper than AED, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 35.39
EV/EBITDA 22.49
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AED does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of AED may justify a higher PE ratio.
PEG (NY)3.86
PEG (5Y)N/A
EPS Next 2Y3.32%
EPS Next 3Y3.19%

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.68%, AED has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 5.29, AED is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.81, AED pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

  • On average, the dividend of AED grows each year by 22.82%, which is quite nice.
Dividend Growth(5Y)22.82%
Div Incr Years1
Div Non Decr Years1
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

5.3 Sustainability

  • 105.58% of the earnings are spent on dividend by AED. This is not a sustainable payout ratio.
  • The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP105.58%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AEDIFICA

EBR:AED (2/25/2026, 3:51:11 PM)

77.15

-1 (-1.28%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-13
Earnings (Next)04-27
Inst Owners41.34%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap3.67B
Revenue(TTM)358.28M
Net Income(TTM)175.81M
Analysts82.22
Price Target80.37 (4.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP105.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.15%
PT rev (3m)7.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 16.11
Fwd PE 14.68
P/S 10.4
P/FCF 35.39
P/OCF 12.56
P/B 1.03
P/tB 1.06
EV/EBITDA 22.49
EPS(TTM)4.79
EY6.21%
EPS(NY)5.26
Fwd EY6.81%
FCF(TTM)2.18
FCFY2.83%
OCF(TTM)6.14
OCFY7.96%
SpS7.42
BVpS74.59
TBVpS72.74
PEG (NY)3.86
PEG (5Y)N/A
Graham Number89.66
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROCE 4.69%
ROIC 3.52%
ROICexc 3.55%
ROICexgc 3.61%
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
FCFM 29.37%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexgc growth 3Y6.29%
ROICexgc growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Debt/EBITDA 7.41
Cap/Depr 6078.86%
Cap/Sales 53.38%
Interest Coverage 250
Cash Conversion 105.31%
Profit Quality 58.95%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.93
F-Score7
WACC6.3%
ROIC/WACC0.56
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
EPS Next Y4.17%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
EPS Next 5YN/A
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year10.51%
EBIT Next 3Y6.39%
EBIT Next 5YN/A
FCF growth 1Y142.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3Y7.82%
OCF growth 5Y22.86%

AEDIFICA / AED.BR FAQ

What is the fundamental rating for AED stock?

ChartMill assigns a fundamental rating of 4 / 10 to AED.BR.


What is the valuation status of AEDIFICA (AED.BR) stock?

ChartMill assigns a valuation rating of 3 / 10 to AEDIFICA (AED.BR). This can be considered as Overvalued.


How profitable is AEDIFICA (AED.BR) stock?

AEDIFICA (AED.BR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for AED stock?

The Price/Earnings (PE) ratio for AEDIFICA (AED.BR) is 16.11 and the Price/Book (PB) ratio is 1.03.


Can you provide the financial health for AED stock?

The financial health rating of AEDIFICA (AED.BR) is 2 / 10.